NCT Number: NCT05806515
Phase: PHASE2
Trial Summary: This phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation. Carboplatin is in a class of medi – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): SWOG Cancer Research Network
Acronym:
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives